Senior insider sale
KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$1.28M
15K shares
What this filing means
RIDLOFF ELENA plans to sell 15K shares of KYMERA THERAPEUTICS, INC. valued at approximately $1.28M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001950047-26-004332
15K
Shares to sell
$1.28M
Approx. market value
3K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/11/2026
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/11/2026 | Exercise of Stock Options Cash | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.60K
Market value
$392.9K
4/1/2026
—Completed
Units to sell
7.40K
Market value
$631.7K
3/31/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3K
Market value
$258.2K
5/11/2026
Total
Units
15K
Value
$1.28M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 4.60K | $392.9K | — | Completed |
3/31/2026 | 7.40K | $631.7K | — | Completed |
| Planned — Approximate Date | ||||
5/11/2026 | 3K | $258.2K | NASDAQ | Planned |
| Total | 15K | $1.28M | ||